Skip to content

Rapport Therapeutics

US · RAPP #2970 by market cap Listed 2024
23.16 -0.43 -1.82%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Quant vs Street three independent views, side by side

StockVane factor grade
C+
Momentum strategy signal
Sell
Analyst consensus
Buy

Signals diverge - worth digging into why.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

Analyst consensus 14 analysts

Buy
Avg price target 68.00 +193.6%
Price target rangecurrent 23.16
Low47.00
Avg68.00
High91.00
Buy 100% Hold 0% Sell 0%
Recent ratings (25)
DateFirmAnalystRatingTarget
2026-11-12 JonesTrading -- Buy 82.00
2026-11-05 Wells Fargo -- Buy 47.00
2026-11-05 UBS -- Buy 64.00
2026-11-05 H.C. Wainwright -- Buy 63.00
2026-11-04 Wells Fargo -- Buy 47.00
2026-11-04 Guggenheim -- Buy 66.00
2026-10-21 Wells Fargo -- Buy 50.00
2026-10-21 JonesTrading -- Buy 82.00
2026-10-21 Goldman Sachs -- Buy 68.00
2026-10-20 Wells Fargo -- Buy 50.00
2026-10-20 Raymond James -- Buy 86.00
2026-10-20 Citizens JMP -- Buy 91.00
2026-10-20 Guggenheim -- Buy 70.00
2026-10-20 H.C. Wainwright -- Buy 66.00
2026-10-16 Wells Fargo -- Buy 51.00
2026-10-15 Wolfe Research -- Buy 50.00
2026-10-05 Guggenheim -- Buy 65.00
2026-10-01 BTIG -- Buy 75.00
2026-09-23 William Blair -- Buy --
2026-09-23 Raymond James -- Buy --
2026-09-23 Truist Financial -- Buy --
2026-09-23 H.C. Wainwright -- Buy 66.00
2026-09-22 TD Cowen -- Buy --
2026-09-22 BTIG -- Buy 75.00
2026-09-22 Goldman Sachs -- Buy 62.00

Price target trend monthly average, last 3 years

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Rapport Therapeutics discussion 0 comments

Add a comment